查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1492342

血流感染檢測市場：按產品類型、技術和最終用途分類 - 2024-2030 年全球預測

Bloodstream Infection Testing Market by Product (Instruments, Reagents & Consumables), Sample Type (Blood Culture, Whole Blood), Technology, End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年血流感染檢測市場規模為11.2億美元，預計2024年將達12億美元，2030年將達18.8億美元，複合年成長率為7.64%。

血流感染檢測市場包括各種診斷和分析技術，用於識別血液中導致全身感染的病原體和污染物。血流感染疾病在全球範圍內迅速增加，增加了對有效檢測解決方案的需求。診斷技術的進步正在提高血液檢測的速度和準確性。全球醫療保健支出的增加將推動先進診斷解決方案的採用。然而，嚴格的監管要求漫長而複雜，減緩了新測試進入市場的速度。特別是在新興市場，經常缺乏能夠執行和解釋高階診斷測試的技術人員，從而造成市場進入挑戰。此外，人工智慧和機器學習可用於完善診斷過程，使其更快、更準確。無需大型實驗室即可現場快速測試的可攜式設備的開拓可能為市場帶來巨大的成長機會。

主要市場統計
基準年[2023] 11.2億美元
預測年份 [2024] 12億美元
預測年份 [2030] 18.8億美元
複合年成長率（%） 7.64%

區域洞察

由於先進的醫療基礎設施和 FDA 對診斷方法的嚴格規定，血流感染檢測在美洲地區受到高度重視。在美國和加拿大，消費者對先進診斷的可用性的認知很高，這推動了對尖端測試解決方案的需求。在歐洲國家，由於發達的公共醫療保健系統和高標準的患者照護，血流感染檢測技術的採用普遍增加。由於醫療保健支出增加以及醫院設施現代化的努力（包括採用自動化微生物檢測系統以提高診斷效率和準確性），中東是一個不斷成長的市場。儘管非洲是多樣化的，一些地區由於醫療基礎設施有限而面臨挑戰，但國際援助機構和各國政府正在積極努力提高其檢測感染疾病的能力，其中也包括失控感染的檢測。在亞太地區，由於政府旨在提高醫療保健整體品質的醫療改革，中國血流感染檢測市場正在迅速擴大。憑藉政府對醫療保健技術研究的大力支持，日本企業往往處於推出創新診斷產品的最前線。由於醫療基礎設施的改善和政府加大醫療改革舉措，特別是注重減輕感染疾病的整體負擔，印度的血液感染檢測正在強勁成長。

FPNV定位矩陣

FPNV 定位矩陣對於評估供應商在血流感染測試市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對血流感染檢測市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭力的寶貴見解，包括研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在血流感染檢測市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的血流感染疾病呈上升趨勢
      • 使用基於血液的診斷策略的趨勢
      • 政府旨在提高人們對血液相關疾病的認知並改善血液安全的舉措
    • 抑制因素
      • 報銷政策複雜且保險範圍不足
    • 機會
      • 旨在開發新的血液檢測、基於血液的抗菌檢測和次世代定序的研究活動
      • 採用人工智慧、機器學習技術和新生物標記進行血流感染檢測
    • 任務
      • 血流感染檢測的技術和臨床局限性以及污染的可能性
  • 市場區隔分析
    • 產品：探索血流感染檢測設備以獲得快速可靠的檢測結果
    • 最終用途：診斷中心的多功能用途，以實現高效測試
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章血流感染檢測市場：依產品

  • 裝置
  • 試劑/耗材

第7章依樣本類型分類的血流感染檢測市場

  • 血液培養
  • 全血

第8章血流感染檢測市場：依技術分類

  • 原位雜合技術
  • 質譜
  • PCR

第9章血流感染檢測市場：依最終用途分類

  • 學術研究所
  • 診斷中心
  • 醫院

第10章 北美和南美血流感染檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太血流感染檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的血流感染檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • 將血液檢測和人工智慧結合，實現敗血症管理中的高階診斷、早期檢測和風險評估
    • 戰略夥伴關係加強了波蘭對血流感染疾病和敗血症的診斷
    • Oxford Nanopore 與 Day Zero Diagnostics 之間的創新合作，用於快速血流感染疾病診斷
  • 戰略分析和建議

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-4D00F1312BD4

[181 Pages Report] The Bloodstream Infection Testing Market size was estimated at USD 1.12 billion in 2023 and expected to reach USD 1.20 billion in 2024, at a CAGR 7.64% to reach USD 1.88 billion by 2030.

The bloodstream infection testing market includes a range of diagnostic and analytical techniques used to identify pathogens or contaminants in the blood that lead to systemic infections. The surge in cases of bloodstream infections globally fuels the need for effective testing solutions. Technological advancements in diagnostic technologies enhance the speed and accuracy of blood tests. Increased healthcare expenditure worldwide fuels the adoption of advanced diagnostic solutions. However, stringent regulatory requirements can be lengthy and complex, delaying market entry for new tests. Especially in emerging markets, there is often a shortage of skilled personnel to perform and interpret advanced diagnostic tests, creating challenges in the market space. Moreover, leveraging artificial intelligence and machine learning can refine diagnostic processes, making them faster and more accurate. The development of portable devices for rapid at-site testing without the need for extensive lab facilities may create significant growth opportunities in the market.

KEY MARKET STATISTICS
Base Year [2023] USD 1.12 billion
Estimated Year [2024] USD 1.20 billion
Forecast Year [2030] USD 1.88 billion
CAGR (%) 7.64%

Regional Insights

In the Americas region, bloodstream infection testing is highly prioritized due to the advanced healthcare infrastructure and stringent regulations by the FDA regarding diagnostic procedures. There is a high level of consumer awareness in the United States and Canada regarding the availability of advanced diagnostics, which drives demand for cutting-edge testing solutions. European countries typically show a strong adoption of bloodstream infection testing technologies due to their well-funded public health systems and high patient care standards. The Middle East presents a growing market, with increasing healthcare expenditure and initiatives to modernize hospital facilities, including adopting automated systems for microbial testing to enhance the efficiency and accuracy of diagnostics. Africa is diverse; while some regions face challenges due to limited healthcare infrastructure, there is a significant effort by international aid organizations and governments to improve infectious disease detection capabilities, which includes bloodstream infection testing. In the Asia Pacific region, China's market for bloodstream infection testing is expanding rapidly, driven by government health reforms aimed at improving the overall quality of healthcare. Due to strong governmental support for healthcare technology research, Japanese companies are often at the forefront of launching innovative diagnostic products. India is seeing significant growth in bloodstream infection testing, driven by both rising healthcare infrastructure and increased government initiatives towards healthcare reform, particularly focused on decreasing the overall burden of infectious diseases

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Bloodstream Infection Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising number of bloodstream infections across the world
      • Inclination towards utilization of blood-based diagnostics strategies
      • Government initiatives to raise awareness about blood-related diseases and improve blood safety
    • Market Restraints
      • Complex reimbursement policies and inadequate insurance coverage
    • Market Opportunities
      • Research activities to develop novel blood tests, blood-based antimicrobial tests, and next-generation sequencing
      • Adoption of AI, ML technologies, and new biomarkers for bloodstream infection testing
    • Market Challenges
      • Technical and clinical limitations of bloodstream infection testing and chances of contamination
  • Market Segmentation Analysis
    • Product: Exploring bloodstream infection testing instruments for rapid and reliable test results
    • End-use: Diverse scope of applications in diagnostic centers for efficient testing
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Bloodstream Infection Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Bloodstream Infection Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Advanced Diagnostics in Sepsis Management, Integrating Blood Testing and AI for Early Detection and Risk Assessment

In a significant breakthrough in medical diagnostics, researchers have developed a dual approach combining a blood test and artificial intelligence to enhance the early detection of sepsis, potentially saving countless lives. Sepsis, a critical condition marked by the body's overwhelming and life-threatening response to infection. Despite the need for further clinical validation before widespread implementation, this approach represents a promising advancement in the fight against sepsis, aligning with the goals of enhancing diagnostic precision and improving patient prognoses. [Published On: 2024-03-29]

Strategic Partnership Enhances Bloodstream Infection and Sepsis Diagnostics in Poland

Becton, Dickinson and Company (BD) has formed a strategic alliance with The Great Orchestra of Christmas Charity (GOCC), to bolster the country's capabilities in diagnosing bloodstream infections (BSIs) and managing sepsis. This partnership is set to equip over 150 Polish healthcare facilities with sophisticated diagnostic systems such as the BD Bruker MALDI Biotyper sirius IVD System and the BD Phoenix M50 Systems. This initiatives are aligned with BD's commitment to improve health access and equity within the region, facilitating faster and more accurate medical responses essential for tackling the global health challenges. [Published On: 2024-03-15]

Innovative Collaboration for Rapid Bloodstream Infection Diagnostics, Oxford Nanopore and Day Zero Diagnostics Join Forces

Oxford Nanopore Technologies and Day Zero Diagnostics have entered into a strategic collaboration to revolutionize the diagnosis of bloodstream infections, an essential step in mitigating sepsis risks. This initiative aims to establish a comprehensive diagnostic system capable of offering same-day identification and genomic-based assessments of antibiotic resistance, directly from patient samples without the reliance on traditional blood cultures. [Published On: 2023-11-17]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Bloodstream Infection Testing Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Bloodstream Infection Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., Advacare Pharma, Bactiguard AB, Becton, Dickinson and Company, BioMerieux, Bruker Corporation, Cardinal Health, Cepheid, CorMedix Inc., Diasorin S.p.A., F. Hoffmann-La Roche Ltd, Fresenius Medical Care AG & Co. KGaA, HiMedia Laboratories Pvt. Ltd, ITL Health Group, Johnson & Johnson Services, Inc, Kurin Inc., Merck & Co., Inc., Novartis AG, Novo Holdings A/S, Pfizer Inc., Pro-Lab Diagnostics, Sanofi S.A., Sepsis Alliance, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Bloodstream Infection Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
    • Reagents & Consumables
  • Sample Type
    • Blood Culture
    • Whole Blood
  • Technology
    • In Situ Hybridization
    • Mass Spectroscopy
    • PCR
  • End-use
    • Academic & Research Institutes
    • Diagnostic Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of bloodstream infections across the world
      • 5.1.1.2. Inclination towards utilization of blood-based diagnostics strategies
      • 5.1.1.3. Government initiatives to raise awareness about blood-related diseases and improve blood safety
    • 5.1.2. Restraints
      • 5.1.2.1. Complex reimbursement policies and inadequate insurance coverage
    • 5.1.3. Opportunities
      • 5.1.3.1. Research activities to develop novel blood tests, blood-based antimicrobial tests, and next-generation sequencing
      • 5.1.3.2. Adoption of AI, ML technologies, and new biomarkers for bloodstream infection testing
    • 5.1.4. Challenges
      • 5.1.4.1. Technical and clinical limitations of bloodstream infection testing and chances of contamination
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Exploring bloodstream infection testing instruments for rapid and reliable test results
    • 5.2.2. End-use: Diverse scope of applications in diagnostic centers for efficient testing
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Bloodstream Infection Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables

7. Bloodstream Infection Testing Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Blood Culture
  • 7.3. Whole Blood

8. Bloodstream Infection Testing Market, by Technology

  • 8.1. Introduction
  • 8.2. In Situ Hybridization
  • 8.3. Mass Spectroscopy
  • 8.4. PCR

9. Bloodstream Infection Testing Market, by End-use

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Diagnostic Centers
  • 9.4. Hospitals

10. Americas Bloodstream Infection Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Bloodstream Infection Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Bloodstream Infection Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Advanced Diagnostics in Sepsis Management, Integrating Blood Testing and AI for Early Detection and Risk Assessment
    • 13.3.2. Strategic Partnership Enhances Bloodstream Infection and Sepsis Diagnostics in Poland
    • 13.3.3. Innovative Collaboration for Rapid Bloodstream Infection Diagnostics, Oxford Nanopore and Day Zero Diagnostics Join Forces
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BLOODSTREAM INFECTION TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOODSTREAM INFECTION TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BLOODSTREAM INFECTION TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. BLOODSTREAM INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. BLOODSTREAM INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOODSTREAM INFECTION TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BLOOD CULTURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BLOOD CULTURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROSCOPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROSCOPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PCR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. AUSTRALIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 104. AUSTRALIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 105. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 111. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 112. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 113. INDIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. INDIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. INDIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. INDIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 119. INDIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 120. INDIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 121. INDONESIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 122. INDONESIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 123. INDONESIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. INDONESIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 127. INDONESIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 128. INDONESIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 129. JAPAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. JAPAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. JAPAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. JAPAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 135. JAPAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 136. JAPAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 137. MALAYSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. MALAYSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. MALAYSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. MALAYSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 143. MALAYSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 144. MALAYSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 146. PHILIPPINES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. PHILIPPINES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 152. PHILIPPINES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 153. SINGAPORE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 154. SINGAPORE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 155. SINGAPORE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. SINGAPORE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 159. SINGAPORE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 160. SINGAPORE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. SOUTH KOREA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH KOREA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH KOREA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 169. TAIWAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 170. TAIWAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 171. TAIWAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. TAIWAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 175. TAIWAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 176. TAIWAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 177. THAILAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. THAILAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. THAILAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. THAILAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 183. THAILAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 184. THAILAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 185. VIETNAM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 186. VIETNAM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 187. VIETNAM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. VIETNAM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 191. VIETNAM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 192. VIETNAM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 203. DENMARK BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. DENMARK BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. DENMARK BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. DENMARK BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 209. DENMARK BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 210. DENMARK BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 211. EGYPT BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. EGYPT BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. EGYPT BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. EGYPT BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 217. EGYPT BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 218. EGYPT BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 219. FINLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 220. FINLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 221. FINLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. FINLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 225. FINLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 226. FINLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 227. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 228. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 229. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 233. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 234. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 235. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 241. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 242. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 243. ISRAEL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 244. ISRAEL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 245. ISRAEL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. ISRAEL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 249. ISRAEL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 250. ISRAEL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 251. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 252. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 253. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 257. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 258. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 260. NETHERLANDS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. NETHERLANDS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 266. NETHERLANDS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 267. NIGERIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 268. NIGERIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 269. NIGERIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. NIGERIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 273. NIGERIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 274. NIGERIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 275. NORWAY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 276. NORWAY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 277. NORWAY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. NORWAY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 281. NORWAY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 282. NORWAY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 283. POLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 284. POLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 285. POLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. POLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 289. POLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 290. POLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 291. QATAR BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 292. QATAR BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 293. QATAR BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. QATAR BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 297. QATAR BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 298. QATAR BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 299. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 300. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 301. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 305. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 306. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 308. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 314. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 316. SOUTH AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 318. SOUTH AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 322. SOUTH AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 323. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 324. SPAIN BLOODSTREAM INFECTION